KR20220124390A - Cosmetic composition for preventing or improving hair loss symptoms containing black soybean, green tangerine and turmeric extract - Google Patents

Cosmetic composition for preventing or improving hair loss symptoms containing black soybean, green tangerine and turmeric extract Download PDF

Info

Publication number
KR20220124390A
KR20220124390A KR1020210027921A KR20210027921A KR20220124390A KR 20220124390 A KR20220124390 A KR 20220124390A KR 1020210027921 A KR1020210027921 A KR 1020210027921A KR 20210027921 A KR20210027921 A KR 20210027921A KR 20220124390 A KR20220124390 A KR 20220124390A
Authority
KR
South Korea
Prior art keywords
extract
hair loss
preventing
weight
improving hair
Prior art date
Application number
KR1020210027921A
Other languages
Korean (ko)
Other versions
KR102602321B1 (en
Inventor
강유안
김수민
이은희
문규리
김현미
Original Assignee
(주)대한뷰티산업진흥원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)대한뷰티산업진흥원 filed Critical (주)대한뷰티산업진흥원
Priority to KR1020210027921A priority Critical patent/KR102602321B1/en
Publication of KR20220124390A publication Critical patent/KR20220124390A/en
Application granted granted Critical
Publication of KR102602321B1 publication Critical patent/KR102602321B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a composition including a Glycine max seed extract, a Citrus reticulata fruit extract, and a Curcuma longa root extract. The composition including a Glycine max seed extract, a Citrus reticulata fruit extract, and a Curcuma longa root extract according to the present invention is excellent in preventing or alleviating hair loss.

Description

검정콩, 풋귤 및 울금 추출물을 포함하는 탈모 증상 예방 또는 개선용 화장료 조성물{Cosmetic composition for preventing or improving hair loss symptoms containing black soybean, green tangerine and turmeric extract}Cosmetic composition for preventing or improving hair loss symptoms containing black beans, green tangerine and turmeric extracts {Cosmetic composition for preventing or improving hair loss symptoms containing black soybean, green tangerine and turmeric extract}

본 발명은 검정콩, 풋귤 및 울금 추출물을 포함하는 탈모 증상 예방 또는 개선용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for preventing or improving hair loss symptoms comprising extracts of black beans, green tangerines and turmeric.

모발은 머리보호, 외향에 대한 영향, 머리의 온도유지 등 인체에서 다양한 역할을 담당하고 있으며, 생명유지에 중요한 기관은 아니지만, 건강상태의 척도이자 외모를 결정짓는 신체의 중요한 일부분이다.Hair is responsible for various roles in the human body, such as protecting the head, affecting the appearance, and maintaining the temperature of the head.

인체의 모발은 10만 ∼ 15만개 정도로, 각각의 모발은 서로 다른 주기를 가지며 정상모발의 90%를 차지하는 성장기(anagen, growing phase), 생장정지와 모근이 위축되는 퇴행기(catagen, transitional phase), 모구가 건조되고 곤봉모가 되는 휴지기(telogen, resting phase) 등의 모주기(hair cycle)를 거치면서 모발은 성장과 탈모를 거듭한다. 이러한 주기는 3 ∼ 6년에 걸쳐 반복되는데 그 결과 정상적으로 하루 평균 50 ∼ 100개의 모발이 탈락하게 된다.The human body has about 100,000 to 150,000 hairs, and each hair has a different cycle and accounts for 90% of normal hair in the anagen (growing phase), growth stop and catagen (transitional phase), in which the hair roots are atrophied. Hair goes through a hair cycle, such as a telogen, resting phase, in which the hair follicle dries and becomes a club hair, and hair grows and loses hair repeatedly. This cycle is repeated over 3 to 6 years, and as a result, an average of 50 to 100 hairs are normally lost per day.

탈모(alopecia)는 모발의 성장 주기에서 성장기의 모발 비율이 짧아지고 퇴행기 또는 휴지기의 모발이 많아져 비정상적으로 모발의 탈락이 증가하고, 정상적으로 자라던 모발이 어떤 원인에 의해 빠지게 되는 현상을 일컫는다. 스트레스나 질병으로 인한 탈모가 아닌 대부분의 탈모는 모발이 영양을 잃어가며 자연스럽게 굵기가 가늘어지고 약해져서 빠지게 되고, 이런 주기가 빨라지면서 모발이 재생되지 않는 탈모가 되는 것이다. 탈모는 불균형한 식생활, 과다한 음주와 흡연, 약물복용, 수면부족, 스트레스, 출산, 환경오염, 유전, 잦은 파마와 염색, 호르몬의 불균형 등에 기인하여 발생하는 것으로 알려져 있다.Alopecia refers to a phenomenon in which the proportion of hair in the growth phase is shortened in the hair growth cycle and the hair in the degenerative phase or telogen phase increases, abnormally increased hair loss, and the normally grown hair falls out due to some cause. Most hair loss, other than hair loss due to stress or disease, causes the hair to lose nutrients and naturally become thinner and weaker and fall out. Hair loss is known to occur due to unbalanced diet, excessive drinking and smoking, drug use, lack of sleep, stress, childbirth, environmental pollution, heredity, frequent perms and dyeing, and hormone imbalance.

탈모의 치료방법으로는 국소도포제, 경구복용제, 건강보조식품, 모발 이식수술 등이 있으나 이러한 방법들은 사용범위가 한정되어 있고, 지속적인 탈모완화가 이루어지지 않는다. 또한, 약물치료의 효과도 일시적이며, 두피 혹은 피지의 생성을 오히려 가속화시키기도 한다.Hair loss treatment methods include topical application agents, oral medications, health supplements, hair transplant surgery, etc. However, these methods have a limited scope of use, and continuous hair loss relief is not achieved. In addition, the effect of the drug treatment is temporary, and rather accelerates the production of the scalp or sebum.

탈모를 치료하기 위해서 성장기(Anagen)의 모낭세포를 증가시키고, 퇴행기(Catagen)와 휴지기(Telogen)의 세포를 감소시키는 방향으로 접근하고 있다. 탈모진행과정에서 감소하는 Wnt/β-catenin을 활성화시키고, 모발성장인자인 IGF-1, VEGF를 증가시킴으로써 모발 형성에 관여하는 세포를 분화시킨다.To treat hair loss, the approach is to increase hair follicle cells in the growth phase (anagen) and decrease cells in the catagen phase and telogen phase. It activates Wnt/β-catenin, which is decreased in the process of hair loss, and differentiates cells involved in hair formation by increasing IGF-1 and VEGF, which are hair growth factors.

현재 가장 많이 알려져있는 모발성장 촉진제제로서 미녹시딜(minoxidil, 경피도포제) 및 피나스테라이드(finasteride, 경구복용제) 등이 FDA 승인을 얻어 임상적으로 상용되고 있다. 특히 미녹시딜은 1970년 초에 혈관확장제로 최초로 소개되어 약물효과 이외의 부작용이 발모임이 밝혀져 현재 발모촉진제로 사용되고 있으며, 피나스테리드제제는 전립선 비대증 치료제 개발로부터 유래된 5α-reductase 억제효과를 가진 탈모 억제제로 사용되고 있다. 그러나 현재 주로 사용되는 발모제의 약물 이상반응이 보고되고 있어 적극적 치료에 상당한 제한성을 가지고 있다.Minoxidil (transdermal application) and finasteride (oral preparation), which are currently the most well-known hair growth stimulants, have been approved by the FDA and are being used clinically. In particular, minoxidil was first introduced as a vasodilator in the early 1970s, and it was found that side effects other than drug effects were hair growth, so it is currently used as a hair growth promoting agent. is being used However, there are significant limitations in active treatment as adverse drug reactions have been reported for the currently used hair growth agents.

이러한 문제점을 고려하여, 소비자가 믿고 사용할 수 있는 안전하며 탈모완화 및 발모촉진 효능이 우수한 천연 원료 개발이 필요한 실정이다.In consideration of these problems, there is a need for the development of natural raw materials that are safe for consumers to trust and use, and have excellent efficacy in alleviating hair loss and promoting hair growth.

등록특허공보 10-1424175호Registered Patent Publication No. 10-1424175

본 발명의 목적은 탈모 예방 또는 개선용 화장료 조성물을 제공하는 것이다.It is an object of the present invention to provide a cosmetic composition for preventing or improving hair loss.

본 발명의 다른 목적은 탈모 증상 예방 또는 개선용 피부 외용제 조성물을 제공하는 것이다.Another object of the present invention is to provide a composition for external application for skin for preventing or improving hair loss symptoms.

상기 목적을 달성하기 위하여,In order to achieve the above object,

본 발명은 검정콩(Glycine max seed) 추출물, 풋귤(Citrus reticulata fruit) 추출물 및 울금(Curcuma longa root) 추출물을 포함하는 탈모 증상 예방 또는 개선용 화장료 조성물을 제공한다.The present invention provides a cosmetic composition for preventing or improving hair loss symptoms, including a black bean ( Glycine max seed) extract, a Citrus reticulata fruit extract, and a Curcuma longa root extract.

상기 검정콩은 검정콩 원물을 사용할 수도 있고, 바람직하게는 검정콩 유박(defatted Glycine max seed)을 추출 대상물로서 사용할 수 있다.The black soybean may use a black soybean raw material, preferably black soybean oil oil (defatted Glycine max seed) may be used as an extraction target.

또한, 본 발명은 검정콩(Glycine max seed) 추출물, 풋귤(Citrus reticulata fruit) 추출물 및 울금(Curcuma longa root) 추출물을 포함하는 탈모 증상 예방 또는 개선용 피부 외용제 조성물을 제공한다.In addition, the present invention provides a composition for external application for skin for preventing or improving hair loss symptoms, comprising a black bean ( Glycine max seed) extract, a green tangerine ( Citrus reticulata fruit) extract, and a turmeric ( Curcuma longa root) extract.

상기 검정콩은 검정콩 원물을 사용할 수도 있고, 바람직하게는 검정콩 유박(defatted Glycine max seed)을 추출 대상물로서 사용할 수 있다.The black soybean may use a black soybean raw material, preferably black soybean oil oil (defatted Glycine max seed) may be used as an extraction target.

본 발명에 따른 검정콩(Glycine max seed) 추출물, 풋귤(Citrus reticulata fruit) 추출물 및 울금(Curcuma longa root) 추출물을 포함하는 조성물은 탈모 예방 또는 개선 효능이 우수한 효과가 있다.A composition comprising a black bean ( Glycine max seed) extract, a Citrus reticulata fruit extract and a Curcuma longa root extract according to the present invention has an excellent effect in preventing or improving hair loss.

도 1은 검정콩 추출물의 제조 단계를 나타낸 순서도이다.
도 2는 풋귤 추출물의 제조 단계를 나타낸 순서도이다.
도 3은 울금 추출물의 제조 단계를 나타낸 순서도이다.
1 is a flow chart showing the manufacturing steps of black soybean extract.
2 is a flowchart showing the steps of preparing a green tangerine extract.
Figure 3 is a flow chart showing the manufacturing steps of turmeric extract.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

화장료 조성물cosmetic composition

본 발명은 유효물질을 포함하는 화장료 조성물을 제공한다.The present invention provides a cosmetic composition comprising an active substance.

상기 화장료 조성물은, 예를 들면 용액, 겔, 고체 또는 반죽 무수 생성물, 수상에 유상을 분산시켜 얻은 에멀젼, 현탁액, 마이크로에멀젼, 마이크로캡슐, 미세과립구 또는 이온형(리포좀), 비이온형의 소낭 분산제의 형태일 수 있다. 더욱 구체적인 형태로는 화장수, 유액, 크림, 스킨, 로션, 세럼, 에센스, 에멀젼, 파우더, 화장연고, 스프레이, 젤, 팩, 클렌저, 비누, 샴푸, 린스, 입욕제, 세정제 또는 콘실 스틱의 형태로 제공될 수 있다. 또한, 폼(foam)의 형태 또는 압축된 추진제를 더 함유한 에어로졸 조성물의 형태로도 제조될 수 있다.The cosmetic composition is, for example, a solution, a gel, a solid or kneaded anhydrous product, an emulsion obtained by dispersing an oil phase in an aqueous phase, a suspension, a microemulsion, a microcapsule, a microgranule or an ionic (liposome), a nonionic vesicle dispersant may be in the form of More specific forms include lotions, emulsions, creams, skins, lotions, serums, essences, emulsions, powders, cosmetic ointments, sprays, gels, packs, cleansers, soaps, shampoos, conditioners, bathing agents, detergents, or in the form of sticks. can be In addition, it may be prepared in the form of a foam or in the form of an aerosol composition further containing a compressed propellant.

또한, 상기 화장료 조성물은 본 발명의 유효물질에 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다.In addition, the cosmetic composition comprises a fatty substance, an organic solvent, a solubilizer, a thickening agent and a gelling agent, an emollient, an antioxidant, a suspending agent, a stabilizer, a foaming agent, a fragrance, a surfactant, Commonly used in water, ionic or nonionic emulsifiers, fillers, sequestering and chelating agents, preservatives, vitamins, blocking agents, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic actives, lipid vesicles or cosmetics It may contain adjuvants commonly used in the cosmetic field, such as any other ingredients that are used.

본 발명의 유효물질을 함유하는 화장료 조성물에 있어서, 통상적으로 함유되는 화장료 조성물에 본 발명의 유효물질이 0.1 내지 50 중량%, 바람직하게는 1 내지 10 중량%의 양으로 첨가될 수 있다.In the cosmetic composition containing the active substance of the present invention, the active substance of the present invention may be added in an amount of 0.1 to 50% by weight, preferably 1 to 10% by weight, to the cosmetic composition usually contained.

본 발명의 유효물질을 피부 외용제로 사용하는 경우, 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 피부용 외용제에 통상적으로 사용되는 임의의 다른 성분과 같은 피부 과학 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다. 또한, 상기 성분들은 피부 과학 분야에서 일반적으로 사용되는 양으로 도입될 수 있다.When the active substance of the present invention is used as an external preparation for skin, additionally, a fatty substance, an organic solvent, a solubilizer, a thickening agent and a gelling agent, an emollient, an antioxidant, a suspending agent, a stabilizer, a foaming agent, a fragrance, a surfactant , water, ionic or non-ionic emulsifiers, fillers, sequestering and chelating agents, preservatives, vitamins, blocking agents, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles or for external use on the skin It may contain adjuvants commonly used in the field of dermatology, such as any other ingredients used as a skin care product. In addition, the above ingredients may be introduced in an amount generally used in the field of dermatology.

피부 외용제 조성물Composition for external application for skin

본 발명의 조성물에 포함되는 성분은 상기 유효성분 이외에 피부 외용제 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체, 부형제 및/또는 희석제를 포함할 수 있다. 제제화에 적합한 담체, 부형제 및 희석제의 예로는, 락토즈, 덱스트로즈, 수크로즈, 솔비톨, 만니톨, 자일리톨, 에리스리톨, 말디톨, 전분, 아카시아고무, 알지네이트, 젤라틴, 칼슘포스페이트, 칼슘실리케이트, 셀룰로즈, 메틸셀룰로즈, 미정질셀룰로즈, 폴리비닐피롤리돈, 물, 메틸하이드록시벤조에이트, 프로필하이드록시벤조에이트, 탈크, 마그네슘스테아레이트 또는 광물유 등이 사용될 수 있다.The ingredients included in the composition of the present invention may include ingredients commonly used in external composition for skin in addition to the active ingredient, for example, conventional adjuvants such as antioxidants, stabilizers, solubilizers, vitamins, pigments and fragrances, and carriers, excipients and/or diluents. Examples of suitable carriers, excipients and diluents for formulation include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, malditol, starch, acacia gum, alginate, gelatin, calcium phosphate, calcium silicate, cellulose, Methylcellulose, microcrystalline cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate or mineral oil may be used.

의약품에 적용할 경우에는 통상 사용되는 무기 또는 유기의 담체를 가하여 고체, 반고체 또는 액상의 형태로 비경구 투여제로 제제화할 수 있다.When applied to pharmaceuticals, it can be formulated as a parenteral administration in the form of a solid, semi-solid or liquid by adding a commonly used inorganic or organic carrier.

본 발명의 유효성분을 제제화하기 위해서는 상법에 따라서 실시하면 용이하게 제제화할 수 있으며 계면활성제, 부형제, 착색료, 향신료, 보존제, 안정제, 완충제, 현탁제, 기타 상용화하는 보조제를 적당히 사용할 수 있다.In order to formulate the active ingredient of the present invention, it can be easily formulated according to a conventional method, and surfactants, excipients, colorants, spices, preservatives, stabilizers, buffers, suspending agents, and other compatibilizing adjuvants can be appropriately used.

본 발명의 피부 외용제 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 연고, 패치, 젤, 크림 또는 분무제의 형태로 제형화될 수 있으나, 이에 한정되는 것은 아니다.The composition for external application for skin of the present invention may be prepared in any formulation conventionally prepared in the art, for example, may be formulated in the form of an ointment, patch, gel, cream or spray, but is not limited thereto. .

이하, 본 발명을 하기의 실시예에 의하여 더욱 상세하게 설명한다. 단, 하기의 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기의 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the following examples only illustrate the present invention, and the content of the present invention is not limited by the following examples.

<제조예 1> 검정콩(<Preparation Example 1> Black beans ( Glycine maxGlycine max seed) 추출물의 제조 seed) preparation of extract

도 1의 제조 단계와 같이 검정콩 추출물을 제조하였다. 검정콩(Glycine max) 씨앗을 압착 착유하여 유박을 얻는다. 상기 유박 50 g에 정제수 1L 혼합 후 프로테아제로서 Protamex®(제조사: novozymes) 및 Flavourzyme®(제조사: novozymes) 각각 0.5g 혼합하여, 50℃에서 4시간 동안 효소가수분해하여 추출액을 얻었다. 상기 추출액을 filter paper (Filter paper, Hyundai Micro, 1~2 ㎛)로 여과하였다. 상기 여과한 여과액은 우선 90℃에서 5분이상 가열하여 비활성화시킨 다음 동결건조기로 건조하여 검정콩 추출물을 제조하였다.Black soybean extract was prepared as in the preparation step of FIG. 1 . Black soybean ( Glycine max ) seeds are pressed and milked to obtain oilmeal. After mixing 1L of purified water with 50 g of the oil cake, 0.5 g of each of Protamex ® (manufacturer: novozymes) and Flavorzyme ® (manufacturer: novozymes) as a protease was mixed, and enzymatically hydrolyzed at 50° C. for 4 hours to obtain an extract. The extract was filtered with filter paper (Filter paper, Hyundai Micro, 1-2 μm). The filtered filtrate was first inactivated by heating at 90° C. for 5 minutes or more, and then dried with a freeze dryer to prepare a black soybean extract.

<제조예 2> 풋귤(<Preparation Example 2> Green tangerine ( Citrus reticulataCitrus reticulata fruit) 추출물의 제조 fruit) Preparation of extract

도 2의 제조단계와 같이 풋귤 추출물을 제조하였다. 풋귤 미성숙 열매(Citrus reticulata fruit) 100 g에 추출용매로 증류수 900 mL을 넣고 shaking water bath(KMC-1205SW1, Vision, 대전, 한국)에서 90℃, 3시간 추출하여 추출액을 얻었다. 상기 추출액을 filter paper (Filter paper, Hyundai Micro, 1~2 ㎛)로 여과하였다. 상기 여과한 여과액을 동결건조기를 이용하여 건조하여 풋귤 추출물을 제조하였다.A green tangerine extract was prepared as in the preparation step of FIG. 2 . To 100 g of unripe Citrus reticulata fruit, 900 mL of distilled water was added as an extraction solvent, and extraction was performed at 90° C. for 3 hours in a shaking water bath (KMC-1205SW1, Vision, Daejeon, Korea) to obtain an extract. The extract was filtered with filter paper (Filter paper, Hyundai Micro, 1-2 μm). The filtered filtrate was dried using a freeze dryer to prepare a green tangerine extract.

<제조예 3> 울금(<Preparation Example 3> Turmeric ( Curcuma longaCurcuma longa root) 추출물의 제조 root) preparation of extract

도 3의 제조 단계와 같이 울금 추출물을 제조하였다. 울금(Curcuma longa) 뿌리 100 g에 추출용매로 증류수 900 mL을 넣고 shaking water bath(KMC-1205SW1, Vision, Daejeon, Korea)에서 90℃, 3시간 추출하여 추출액을 얻었다. 상기 추출액을 filter paper (Filter paper, Hyundai Micro, 1~2 ㎛)로 여과하였다. 상기 여과한 여과액을 동결건조기를 이용하여 건조하여 울금 추출물을 제조하였다.A turmeric extract was prepared as in the preparation step of FIG. 3 . To 100 g of turmeric ( Curcuma longa ) roots, 900 mL of distilled water was added as an extraction solvent, and extraction was performed at 90° C. for 3 hours in a shaking water bath (KMC-1205SW1, Vision, Daejeon, Korea) to obtain an extract. The extract was filtered with filter paper (Filter paper, Hyundai Micro, 1-2 μm). The filtered filtrate was dried using a freeze dryer to prepare a turmeric extract.

<실시예 1> 검정콩(<Example 1> Black beans ( Glycine maxGlycine max seed) 추출물, 풋귤( seed) extract, green tangerine ( Citrus reticulataCitrus reticulata fruit) 추출물 및 울금( fruit) extract and turmeric ( Curcuma longaCurcuma longa root) 추출물 혼합물의 제조 root) preparation of extract mixture

제조예 1 내지 3에서 제조한 3종 추출물과 부틸렌글라이콜 및 정제수를 혼합하여 혼합물 시료를 준비하였다.A mixture sample was prepared by mixing the three extracts prepared in Preparation Examples 1 to 3, butylene glycol, and purified water.

구체적으로, 검정콩 추출물 0.1 중량%, 풋귤 추출물 0.1 중량%, 울금 추출물 0.1 중량%, 부틸렌글라이콜 40 중량% 및 정제수 잔량을 혼합하여 시료를 준비하였다.Specifically, a sample was prepared by mixing 0.1% by weight of black bean extract, 0.1% by weight of green tangerine extract, 0.1% by weight of turmeric extract, 40% by weight of butylene glycol and the remaining amount of purified water.

<비교예 1> 검정콩 추출물 시료의 제조<Comparative Example 1> Preparation of black soybean extract sample

제조예 1에서 제조한 검정콩 추출물 0.3 중량%, 부틸렌글라이콜 40 중량% 및 정제수 잔량을 혼합하여 시료를 준비하였다.A sample was prepared by mixing 0.3% by weight of the black soybean extract prepared in Preparation Example 1, 40% by weight of butylene glycol, and the remaining amount of purified water.

<비교예 2> 풋귤 추출물 시료의 제조<Comparative Example 2> Preparation of green tangerine extract sample

제조예 2에서 제조한 풋귤 추출물 0.3 중량%, 부틸렌글라이콜 40 중량% 및 정제수 잔량을 혼합하여 시료를 준비하였다.A sample was prepared by mixing 0.3% by weight of the green tangerine extract prepared in Preparation Example 2, 40% by weight of butylene glycol, and the remaining amount of purified water.

<비교예 3> 울금 추출물 시료의 제조<Comparative Example 3> Preparation of turmeric extract sample

제조예 3에서 제조한 울금 추출물 0.3 중량%, 부틸렌글라이콜 40 중량% 및 정제수 잔량을 혼합하여 시료를 준비하였다.A sample was prepared by mixing 0.3% by weight of the turmeric extract prepared in Preparation Example 3, 40% by weight of butylene glycol, and the remaining amount of purified water.

<비교예 4> 검정콩 추출물 및 풋귤 추출물 포함 시료의 제조<Comparative Example 4> Preparation of samples containing black soybean extract and green tangerine extract

제조예 1에서 제조한 검정콩 추출물 0.15 중량%, 제조예 2에서 제조한 풋귤 추출물 0.15 중량% 및 부틸렌글라이콜 40 중량% 및 정제수 잔량을 혼합하여 시료를 준비하였다.A sample was prepared by mixing 0.15% by weight of the black soybean extract prepared in Preparation Example 1, 0.15% by weight of the green tangerine extract prepared in Preparation Example 2, 40% by weight of butylene glycol, and the remaining amount of purified water.

<비교예 5> 검정콩 추출물 및 울금 추출물 포함 시료의 제조<Comparative Example 5> Preparation of samples containing black soybean extract and turmeric extract

제조예 1에서 제조한 검정콩 추출물 0.15 중량%, 제조예 3에서 제조한 울금 추출물 0.15 중량%, 부틸렌글라이콜 40 중량% 및 정제수 잔량을 혼합하여 시료를 준비하였다.A sample was prepared by mixing 0.15% by weight of the black bean extract prepared in Preparation Example 1, 0.15% by weight of the turmeric extract prepared in Preparation Example 3, 40% by weight of butylene glycol, and the remaining amount of purified water.

<실험예 1> 인간모유두세포 세포생존율 평가<Experimental Example 1> Human hair papilla cell cell viability evaluation

실시예 및 비교예에서 준비한 시료를 인간모유두세포에 처리하여 세포생존율을 평가하여, 탈모 효능을 알아보았다.The samples prepared in Examples and Comparative Examples were treated with human hair papilla cells to evaluate cell viability, and hair loss efficacy was investigated.

WST(high sensitivity water soluble tetrazolium salts)는 세포 내의 디하이드로게나제(dehydrogenase)와 반응하여 포르마잔(formazan)을 생성한다. 따라서 살아있는 세포가 많을수록 포르마잔의 생성이 많아 높은 흡광도를 나타내며, 이를 이용하여 세포의 독성 정도를 판단할 수 있다.High sensitivity water soluble tetrazolium salts (WST) react with dehydrogenase in the cell to generate formazan. Therefore, the more live cells there are, the more formazan is produced, which indicates a high absorbance, which can be used to determine the degree of toxicity of the cells.

본 시험에 사용한 인간모유두세포(Human Follicle Dermal Papilla Cell; 제조사: Promo cell)는 Human Follicle Dermal Papilla Cell Growth Medium (제조사: PromoCell)에 Fetal Calf Serum, Bovine Pituitary Extract, Basic Fibroblast Growth Factor, Insulin을 첨가한 배지에서 37℃, 5% CO2 조건으로 배양시켰다.Human Follicle Dermal Papilla Cell (Manufacturer: Promo cell) used in this test was prepared by adding Fetal Calf Serum, Bovine Pituitary Extract, Basic Fibroblast Growth Factor, and Insulin to Human Follicle Dermal Papilla Cell Growth Medium (Manufacturer: PromoCell). It was cultured in a medium at 37° C., 5% CO 2 condition.

배양된 세포는 96-웰 플레이트에 5 X 103개로 나누어 분주하여 80% 이상 배양되었을 때 시료를 5가지 농도로 처리한 후 24, 48시간 동안 배양하였다. 이후 배지에 WST 기질 용액(모델명: CCK-8; 제조사: Dojindo)을 넣고 37℃에서 2시간 동안 배양하였다.The cultured cells were divided into 5 X 10 3 pieces in a 96-well plate, and when cultured to 80% or more, the samples were treated at 5 concentrations and then cultured for 24 or 48 hours. Then, a WST substrate solution (Model: CCK-8; Manufacturer: Dojindo) was added to the medium and incubated at 37°C for 2 hours.

Microplate reader (VARIOSKAN LUX, Thermo Fisher Scientific)를 이용하여 450nm에서 흡광도(OD)를 측정하고, 아래의 식에 의해 계산하여 세포 생존율을 계산하였다.The absorbance (OD) was measured at 450 nm using a microplate reader (VARIOSKAN LUX, Thermo Fisher Scientific), and the cell viability was calculated by the following equation.

세포생존율(%)= (ODexp-ODblnk)/(ODcon-ODblnk) X 100Cell viability (%) = (OD exp -OD blnk )/(OD con -OD blnk ) X 100

- blank(blnk): WST 기질을 포함하는 배지- blank (blnk): medium containing WST substrate

- Control(con, 음성대조군): 시료 비처리군- Control (con, negative control): untreated group

- Experiment(exp, 실험군): 시료 처리군- Experiment(exp, experimental group): sample treatment group

시료처리 후 배양시간(h)Incubation time after sample treatment (h) 시료 처리농도 (ppm)Sample treatment concentration (ppm) 00 3.1253.125 6.256.25 12.512.5 2525 실시예 1(검정콩+풋귤+울금)Example 1 (black bean + green tangerine + turmeric) 2424 100.000100.000 106.365106.365 112.566112.566 128.214128.214 146.729146.729 4848 103.856103.856 108.131108.131 119.789119.789 164.493164.493 비교예 1(검정콩)Comparative Example 1 (black soybean) 2424 102.854102.854 104.135104.135 109.269109.269 121.583121.583 4848 98.41298.412 100.889100.889 104.887104.887 116.518116.518 비교예 2(풋귤)Comparative Example 2 (Green Tangerine) 2424 101.544101.544 102.178102.178 104.216104.216 109.326109.326 4848 100.654100.654 101.524101.524 102.558102.558 104.213104.213 비교예 3(울금)Comparative Example 3 (turmeric) 2424 101.958101.958 103.569103.569 106.312106.312 112.258112.258 4848 100.998100.998 102.007102.007 103.441103.441 107.481107.481 비교예 4(검정콩+풋귤)Comparative Example 4 (black bean + green tangerine) 2424 103.254103.254 108.269108.269 113.458113.458 131.257131.257 4848 101.303101.303 104.210104.210 108.558108.558 120.087120.087 비교예 5(검정콩+울금)Comparative Example 5 (black soybean + turmeric) 2424 103.026103.026 109.007109.007 118.859118.859 133.251133.251 4848 101.227101.227 105.334105.334 115.589115.589 128.887128.887

상기 표 1에 나타난 바와 같이, 비교예 1 내지 5 대비 실시예 1의 3종 추출물 콤플렉스 시료의 경우 인간모유두세포 생존율이 현저히 향상됨을 확인할 수 있었다. 특히, 25 ppm 처리농도에서 시료처리 배양 24시간 후 대비 48시간 후에 비교예 1 내지 5는 모두 세포 생존율이 감소하는 것으로 나타난 반면에, 실시예 1의 경우 24시간 후 대비 48시간 후에 세포 생존율이 더욱 향상되는 것으로 나타났다.As shown in Table 1, in the case of the three extract complex samples of Example 1 compared to Comparative Examples 1 to 5, it was confirmed that the survival rate of human hair papilla cells was significantly improved. In particular, Comparative Examples 1 to 5 all showed a decrease in cell viability after 48 hours compared to 24 hours after sample treatment at a treatment concentration of 25 ppm, whereas in Example 1, cell viability was higher after 24 hours compared to after 48 hours. appeared to improve.

<실험예 2> 피부 자극성 평가<Experimental Example 2> Skin irritation evaluation

실시예 1 시료의 피부 자극성을 평가하여 안전성을 알아보았다.Example 1 The safety of the sample was evaluated by evaluating the skin irritation.

실시예 1의 시료를 1% 희석액 상태로 준비하여, 성인 31명을 대상으로 하여 24시간 첩포 시험을 실시하였다. 패치 제거 후 30분, 24시간, 48시간에 각각 일차 피부자극 유무를 피부과 전문의가 판정하였다. The sample of Example 1 was prepared in a 1% dilution state, and a 24-hour patch test was performed on 31 adults. A dermatologist judged the presence or absence of primary skin irritation at 30 minutes, 24 hours, and 48 hours after patch removal, respectively.

피부 자극성 점수 시스템은 하기와 같이 하였다.The skin irritation scoring system was as follows.

<피부 자극성 점수 시스템 표><Skin irritation score system table>

Figure pat00001
Figure pat00001

연구 대상자들의 피부 반응 점수를 이용하여 다음과 같이 자극지수를 계산하였다.The irritation index was calculated as follows using the skin response scores of the study subjects.

Figure pat00002
Figure pat00002

평균 자극 지수를 산출한 후 Draize Dermal Classification System 및 EPA (Environmental Protection Agency) Standard Procedure Dermal Classification System을 응용한 다음 결과 판정표에 따라 자극성의 정도를 판정한다.After calculating the average irritation index, the Draize Dermal Classification System and EPA (Environmental Protection Agency) Standard Procedure Dermal Classification System are applied, and then the degree of irritation is determined according to the result judgment table.

자극 지수stimulus index 자극성 평가Irritation Assessment 0≤ <0.020≤ <0.02 무자극non-irritant 0.02≤ <0.250.02≤ <0.25 저자극hypoallergenic 0.25≤ <10.25≤ <1 경자극mild stimulation 1≤ <2.51≤ <2.5 중자극central stimulus 2.51≤2.51≤ 강자극strong stimulus

피부반응 판정은 ICDRG(International contact dermatitis research group) 기준 및 PCPC(Personal Care Products Council) 가이드라인에 의거하였으며, 31명 연구대상자들의 피부반응 점수를 이용하여 자극 지수를 산출한 결과 피부자극 지수 0.027점을 얻어, 저자극 시료임을 확인하였다.Skin reaction determination was based on ICDRG (International contact dermatitis research group) standards and PCPC (Personal Care Products Council) guidelines. obtained, and it was confirmed that it was a hypoallergenic sample.

화장료의 제조예Preparation example of cosmetics

본 발명에 따른 유효물질은 목적에 따라 여러 형태의 화장료로 제조 가능하다. 하기는 본 발명에 따른 유효물질을 활성성분으로 함유시킨 몇몇 화장료의 제조방법을 예시한 것으로 본 발명이 이에 한정되는 것은 아니다.The active substance according to the present invention can be prepared into various types of cosmetics depending on the purpose. The following exemplifies the manufacturing method of several cosmetics containing the active ingredient according to the present invention as an active ingredient, but the present invention is not limited thereto.

<화장료 제조예 1> 유연 화장수의 제조<Cosmeceutical preparation example 1> Preparation of softened lotion

유효물질 10.0 중량부active substance 10.0 parts by weight

1,3-부틸렌글리콜 1.00 중량부1,3-butylene glycol 1.00 parts by weight

디소듐이디티에이 0.05 중량부Disodium EDIT 0.05 parts by weight

알란토인 0.10 중량부allantoin 0.10 parts by weight

디포타슘글리시리제이트 0.05 중량부Dipotassium glycyrrhizate 0.05 parts by weight

시트르산 0.01 중량부citric acid 0.01 parts by weight

소듐시트레이트 0.02 중량부sodium citrate 0.02 parts by weight

글리세레스-26 1.00 중량부Glyceres-26 1.00 parts by weight

알부틴 2.00 중량부arbutin 2.00 parts by weight

하이드로제네이티드캐스터오일 1.00 중량부Hydrogenated Castor Oil 1.00 parts by weight

에탄올 30.0 중량부ethanol 30.0 parts by weight

보존제 미량preservative a very small amount

착색제 미량coloring agent a very small amount

착향제 미량flavoring agent a very small amount

정제수 잔량Purified water remaining amount

<화장료 제조예 2> 영양 크림의 제조<Cosmeceutical Preparation Example 2> Preparation of nourishing cream

유효물질 10.0 중량부active substance 10.0 parts by weight

1,3-부틸렌글리콜 7.00 중량부1,3-butylene glycol 7.00 parts by weight

글리세린 1.00 중량부glycerin 1.00 parts by weight

D-판테놀 0.10 중량부D-Panthenol 0.10 parts by weight

식물 추출물 3.20 중량부plant extract 3.20 parts by weight

마그네슘알루미늄실리케이트 0.30 중량부Magnesium Aluminum Silicate 0.30 parts by weight

PEG-40 스테아레이트 1.20 중량부PEG-40 Stearate 1.20 parts by weight

스테아르산 2.00 중량부stearic acid 2.00 parts by weight

폴리소르베이트 60 1.50 중량부Polysorbate 60 1.50 parts by weight

친유형글리세릴스테아레이트 2.00 중량부Lipophilic Glyceryl Stearate 2.00 parts by weight

소르비탄세스퀴올리에이트 1.50 중량부Sorbitan sesquioleate 1.50 parts by weight

세테아릴알코올 3.00 중량부cetearyl alcohol 3.00 parts by weight

미네랄오일 4.00 중량부mineral oil 4.00 parts by weight

스쿠알란 3.80 중량부squalane 3.80 parts by weight

카르릴릭/카프릭트리글리세라이드 2.80 중량부Carlylic/Capric Triglycerides 2.80 parts by weight

식물성오일 1.80 중량부vegetable oil 1.80 parts by weight

디메치콘 0.40 중량부dimethicone 0.40 parts by weight

디포슘글리시리제이트 미량Dipotassium glycyrrhizate a very small amount

알란토인 미량allantoin a very small amount

소듐 히아루로네이트 미량Sodium Hyaluronate a very small amount

토코페릴아세테이트 적량Tocopheryl Acetate appropriate amount

트리에탄올아민 적량triethanolamine appropriate amount

보존제 적량preservative appropriate amount

착향제 적량flavoring agent appropriate amount

정제수 잔량Purified water remaining amount

피부 외용제의 제조예Preparation example of external preparation for skin

본 발명에 따른 유효물질은 목적에 따라 여러 형태로 제제화가 가능하다. 하기는 본 발명에 따른 유효물질을 활성성분으로 함유시킨 몇몇 제제화 방법을 예시한 것으로 본 발명이 이에 한정되는 것은 아니다.The active substance according to the present invention can be formulated in various forms depending on the purpose. The following exemplifies some formulation methods containing the active substance according to the present invention as an active ingredient, but the present invention is not limited thereto.

<피부 외용제 제조예 1> 분무제의 제조<Skin external preparation Preparation Example 1> Preparation of spray

유효물질 100 mgactive substance 100 mg

이성화당 10 gLee Seonghwadang 10 g

만니톨 5 gmannitol 5 g

정제수 적량Purified water appropriate amount

통상의 분무제의 제조방법에 따라, 정제수에 각각의 성분을 가하여 용해시키고 레몬 향을 가한 다음 상기의 성분을 혼합한 다음 정제수를 가하여 전체 100 mL로 조절한 후 갈색 병에 충진하고 멸균시켜 분무제를 제조하였다.According to a conventional method for producing a spray, add each component to purified water to dissolve, add lemon flavor, mix the above ingredients, add purified water to adjust the total to 100 mL, fill in a brown bottle, and sterilize to prepare a spray did.

<피부 외용제 제조예 2> 젤제의 제조<Production Example 2 for external application for skin> Preparation of gel

유효물질 100 mgactive substance 100 mg

에탄올 10 gethanol 10 g

글리세린 4 gglycerin 4 g

프로필렌글리콜 4 gpropylene glycol 4 g

폴리옥시에틸렌 경화피마자유 0.1 gPolyoxyethylene hydrogenated castor oil 0.1 g

카르복시폴리머 0.3 gcarboxy polymer 0.3 g

트리에탄올아민 0.3gtriethanolamine 0.3g

산화방지제 적량antioxidant appropriate amount

향료 적량Spices appropriate amount

방부제 적량antiseptic appropriate amount

정제수 적량Purified water appropriate amount

통상의 젤제의 제조방법에 따라, 정제수에 각각의 성분을 가하여 용해시키고 향료를 가한 다음 상기의 성분들을 혼합하여 젤제를 제조하였다.According to a conventional gel preparation method, each component was added and dissolved in purified water, a fragrance was added, and then the above components were mixed to prepare a gel.

<피부 외용제 제조예 3> 연고제의 제조<Skin external preparation Preparation Example 3> Preparation of ointment

유효물질 100 mgactive substance 100 mg

세토스테아릴알코올 2 gcetostearyl alcohol 2 g

자가유화형 모노스테아린산 2 gSelf-emulsifying monostearic acid 2 g

스테아린산 1 gstearic acid 1 g

밀납 4 gbeeswax 4 g

스쿠알란 7 gsqualane 7 g

모노스테아린 글리세린 3 gmonostearin glycerin 3 g

모노스테아린산 소르비탄 1 gMonostearate Sorbitan 1 g

폴리솔베이트 80 3 gPolysorbate 80 3 g

글리세린 5 gglycerin 5 g

프로필렌글리콜 4 gpropylene glycol 4 g

향료 적량Spices appropriate amount

바세린 잔량Vaseline remaining amount

통상의 연고제의 제조방법에 따라, 바세린에 각각의 성분을 가하여 용해시키고 향료를 가한 다음 상기의 성분들을 혼합하여 연고제를 제조하였다.According to a conventional method for preparing an ointment, each component was added to and dissolved in vaseline, a fragrance was added, and then the above components were mixed to prepare an ointment.

이제까지 본 발명에 대하여 그 바람직한 실시예들을 중심으로 살펴보았다. 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자는 본 발명이 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 변형된 형태로 구현될 수 있음을 이해할 수 있을 것이다. 그러므로 개시된 실시예들은 한정적인 관점이 아니라 설명적인 관점에서 고려되어야 한다. 본 발명의 범위는 전술한 설명이 아니라 특히 청구범위에 나타나 있으며, 그와 동등한 범위 내에 있는 모든 차이점은 본 발명에 포함된 것으로 해석되어야 할 것이다.So far, with respect to the present invention, the preferred embodiments have been looked at. Those of ordinary skill in the art to which the present invention pertains will understand that the present invention may be implemented in a modified form without departing from the essential characteristics of the present invention. Therefore, the disclosed embodiments are to be considered in an illustrative rather than a restrictive sense. The scope of the present invention is indicated not in the foregoing description, but in particular in the claims, and all differences within the scope equivalent thereto should be construed as being included in the present invention.

Claims (6)

검정콩(Glycine max seed) 추출물, 풋귤(Citrus reticulata fruit) 추출물 및 울금(Curcuma longa root) 추출물을 포함하는, 탈모 증상 예방 또는 개선용 화장료 조성물.
Black bean ( Glycine max seed) extract, green tangerine ( Citrus reticulata fruit) extract and turmeric ( Curcuma longa root) extract, comprising a, hair loss symptom prevention or improvement cosmetic composition.
제1항에 있어서,
상기 검정콩 추출물은 검정콩 유박(defatted Glycine max seed) 추출물인 것을 특징으로 하는, 탈모 증상 예방 또는 개선용 화장료 조성물.
The method of claim 1,
The black soybean extract is a cosmetic composition for preventing or improving hair loss symptoms, characterized in that the black bean extract is an extract of defatted Glycine max seed.
제1항에 있어서,
상기 화장료는 화장수, 유액, 크림, 스킨, 로션, 세럼, 에센스, 에멀젼, 파우더, 화장연고, 스프레이, 젤, 팩, 클렌저, 비누, 샴푸, 린스, 입욕제, 세정제 또는 콘실 스틱의 형태인 것을 특징으로 하는, 탈모 증상 예방 또는 개선용 화장료 조성물.
The method of claim 1,
The cosmetic is in the form of a lotion, emulsion, cream, skin, lotion, serum, essence, emulsion, powder, cosmetic ointment, spray, gel, pack, cleanser, soap, shampoo, conditioner, bathing agent, detergent or cone stick. A cosmetic composition for preventing or improving hair loss symptoms.
검정콩(Glycine max seed) 추출물, 풋귤(Citrus reticulata fruit) 추출물 및 울금(Curcuma longa root) 추출물을 포함하는, 탈모 증상 예방 또는 개선용 피부 외용제 조성물.
Black bean ( Glycine max seed ) extract, green tangerine ( Citrus reticulata fruit ) extract and turmeric ( Curcuma longa root ) extract, comprising a skin external composition for preventing or improving hair loss symptoms.
제4항에 있어서,
상기 검정콩 추출물은 검정콩 유박(defatted Glycine max seed) 추출물인 것을 특징으로 하는, 탈모 증상 예방 또는 개선용 피부 외용제 조성물.
5. The method of claim 4,
The black soybean extract is a skin external composition for preventing or improving hair loss symptoms, characterized in that the black soybean oil meal (defatted Glycine max seed) extract.
제4항에 있어서,
상기 피부 외용제는 연고, 패치, 젤, 크림 또는 분무제의 형태인 것을 특징으로 하는, 탈모 증상 예방 또는 개선용 피부 외용제 조성물.
5. The method of claim 4,
The external preparation for skin is an ointment, patch, gel, cream or spray, characterized in that the skin external application composition for preventing or improving hair loss symptoms.
KR1020210027921A 2021-03-03 2021-03-03 Cosmetic composition for preventing or improving hair loss symptoms containing black soybean, green tangerine and turmeric extract KR102602321B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020210027921A KR102602321B1 (en) 2021-03-03 2021-03-03 Cosmetic composition for preventing or improving hair loss symptoms containing black soybean, green tangerine and turmeric extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020210027921A KR102602321B1 (en) 2021-03-03 2021-03-03 Cosmetic composition for preventing or improving hair loss symptoms containing black soybean, green tangerine and turmeric extract

Publications (2)

Publication Number Publication Date
KR20220124390A true KR20220124390A (en) 2022-09-14
KR102602321B1 KR102602321B1 (en) 2023-11-14

Family

ID=83278984

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210027921A KR102602321B1 (en) 2021-03-03 2021-03-03 Cosmetic composition for preventing or improving hair loss symptoms containing black soybean, green tangerine and turmeric extract

Country Status (1)

Country Link
KR (1) KR102602321B1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030083159A (en) * 2002-04-19 2003-10-30 주식회사 엘지생활건강 Composition for preventing and treating of androgen-dependent disorders comprising curcuma longa extract
KR20100010647A (en) * 2008-07-23 2010-02-02 (주)아모레퍼시픽 Patch for inhibiting hair loss and enhancing hair growth
KR20110104196A (en) * 2010-03-16 2011-09-22 (주)아모레퍼시픽 Composition for prevention of losing hair or promotion of growing hair
KR20130122070A (en) * 2012-04-30 2013-11-07 (주)아모레퍼시픽 Hair cosmetic composition containing extract of camellia japonica l. seed
KR101424175B1 (en) 2012-12-26 2014-08-01 대구가톨릭대학교산학협력단 Method for producing composition for preventing hair loss or stimulating hair growth with increased antioxidant ability and hair growth ability comprising extracts of black bean, hasuo, gamtae and sea tangle

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030083159A (en) * 2002-04-19 2003-10-30 주식회사 엘지생활건강 Composition for preventing and treating of androgen-dependent disorders comprising curcuma longa extract
KR20100010647A (en) * 2008-07-23 2010-02-02 (주)아모레퍼시픽 Patch for inhibiting hair loss and enhancing hair growth
KR20110104196A (en) * 2010-03-16 2011-09-22 (주)아모레퍼시픽 Composition for prevention of losing hair or promotion of growing hair
KR20130122070A (en) * 2012-04-30 2013-11-07 (주)아모레퍼시픽 Hair cosmetic composition containing extract of camellia japonica l. seed
KR101424175B1 (en) 2012-12-26 2014-08-01 대구가톨릭대학교산학협력단 Method for producing composition for preventing hair loss or stimulating hair growth with increased antioxidant ability and hair growth ability comprising extracts of black bean, hasuo, gamtae and sea tangle

Also Published As

Publication number Publication date
KR102602321B1 (en) 2023-11-14

Similar Documents

Publication Publication Date Title
CA2520057A1 (en) Composition for promoting production of type i collagen and/or elastin
KR102113193B1 (en) Composition for improving skin conditions comprising artemisiae annuae herba, centella asiatica and green tea extract or fraction thereof and method for improving skin conditions using the same
KR20140115400A (en) Composition of scalp care for prevention of depilation and improvement of hair growth comprising Rhus javanica L. Extracts
JP3407935B2 (en) External preparation for skin
KR102099087B1 (en) Composition for Preventing Hair Loss or Improving Hair Growth
JP4796734B2 (en) Matrix metalloprotease activity inhibitor
KR102445830B1 (en) Cosmetic Compositions for Skin Moisture Comprising Extract of Triticum aestivum
JP2002370922A (en) Cosmetic containing japanese plum extract
KR101820531B1 (en) Composition for preventing hair loss or promoting hair growth with Nipa fruticans wurmb
KR101870377B1 (en) Cosmetic composition for improving moisturizing and antioxidant containing ultrasonicating extract of cucumber seed
KR20010018805A (en) Cosmetic compositions for anti-inflammation and anti-irritation containing ponciri fructus extracts as effective ingredients
US10806693B2 (en) Method for increasing lipolysis using a composition comprising bioactive Nelumbo nucifera (lotus) extract
KR101762314B1 (en) Cosmetic composition containing plant extract for improving skin condition
JP4247091B2 (en) Skin anti-aging agent
JPH11246337A (en) Antiaging agent
KR102602321B1 (en) Cosmetic composition for preventing or improving hair loss symptoms containing black soybean, green tangerine and turmeric extract
JP2001081038A (en) Scavenger for active oxygen, and cosmetic and food containing the same scavenger
JPH10182414A (en) Antiaging agent
JP2004149729A (en) Antioxidant
JPH11246387A (en) Antiaging agent
JP2003342179A (en) Agent for aging prevention
KR20210131598A (en) Composition for preventing hair loss or promoting hair growth, comprising Camellia japonica pericarp extract as an active ingredient
KR20230141034A (en) Cosmetic composition for preventing or improving hair loss comprising liposomes containing a mixture of black soybean, green mandarin and turmeric extract
KR20160061601A (en) Cosmetic composition and pharmaceutical composition containing the extract of Corchorus olitorius L, ginko and chlorella
JPH11335230A (en) Skin lotion

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant